MoonLake Immunotherapeuti...

40.41
0.70 (1.76%)
At close: Mar 04, 2025, 3:39 PM

MoonLake Immunotherapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20
PE Ratio -0.03 -82.39 -4.78 -1.45 -1.85K
PEG Ratio -0.00 1.23 0.07 -0.00 n/a
PS Ratio n/a n/a n/a n/a n/a
PB Ratio 0.01 5.98 6.30 -6.66 1.50
P/FCF Ratio -0.03 -68.89 -5.51 -2.2 -531.53
P/OCF Ratio -0.03 -69.35 -5.52 -2.2 -531.53
OCF/S Ratio n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.01 0.01 -1.29 0.00
Quick Ratio 21.11 51.59 9.98 0.39 12.93
Current Ratio 21.11 51.59 9.98 0.46 12.93
Asset Turnover n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.27 -0.07 -1.32 4.61 -0.00
Return on Assets (ROA) -0.25 -0.07 -0.84 -5.54 -0.00
Return on Capital (ROIC) n/a -0.1 -0.94 4.70 -0.00
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a